Literature DB >> 24952244

Critical assessment of human antibody generation in humanized mouse models.

Julien Villaudy1, Remko Schotte2, Nicolas Legrand3, Hergen Spits4.   

Abstract

Immunodeficient mice reconstituted with human hematopoietic stem cells provide a small-animal model for the study of development and function of human hematopoietic cells in vivo. However, in the current models, the immune response, and especially the humoral response by the human immune cells is far from optimal. The B cells found in these mice exhibit an immature and abnormal phenotype correlating with a reduced capacity to produce antigen-specific affinity matured antibodies upon infection or immunization. Herein, we review the current state of knowledge of development, function and antibody production of human B cells and discuss the obstacles for the improvement of these models.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibody; B cell; Human Immune System mouse; Humoral immune response

Mesh:

Substances:

Year:  2014        PMID: 24952244     DOI: 10.1016/j.jim.2014.06.010

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  14 in total

Review 1.  Use of Humanized Mice to Study the Pathogenesis of Autoimmune and Inflammatory Diseases.

Authors:  Iurii Koboziev; Yava Jones-Hall; John F Valentine; Cynthia Reinoso Webb; Kathryn L Furr; Matthew B Grisham
Journal:  Inflamm Bowel Dis       Date:  2015-07       Impact factor: 5.325

Review 2.  Design and engineering of deimmunized biotherapeutics.

Authors:  Karl E Griswold; Chris Bailey-Kellogg
Journal:  Curr Opin Struct Biol       Date:  2016-06-17       Impact factor: 6.809

3.  HSC extrinsic sex-related and intrinsic autoimmune disease-related human B-cell variation is recapitulated in humanized mice.

Authors:  Chiara Borsotti; Nichole M Danzl; Grace Nauman; Markus A Hölzl; Clare French; Estefania Chavez; Mohsen Khosravi-Maharlooei; Salome Glauzy; Fabien R Delmotte; Eric Meffre; David G Savage; Sean R Campbell; Robin Goland; Ellen Greenberg; Jing Bi; Prakash Satwani; Suxiao Yang; Joan Bathon; Robert Winchester; Megan Sykes
Journal:  Blood Adv       Date:  2017-10-13

4.  B Cells Carrying Antigen Receptors Against Microbes as Tools for Vaccine Discovery and Design.

Authors:  Deepika Bhullar; David Nemazee
Journal:  Curr Top Microbiol Immunol       Date:  2019-03-28       Impact factor: 4.291

5.  Structure-based redesign of lysostaphin yields potent antistaphylococcal enzymes that evade immune cell surveillance.

Authors:  Kristina Blazanovic; Hongliang Zhao; Yoonjoo Choi; Wen Li; Regina S Salvat; Daniel C Osipovitch; Jennifer Fields; Leonard Moise; Brent L Berwin; Steven N Fiering; Chris Bailey-Kellogg; Karl E Griswold
Journal:  Mol Ther Methods Clin Dev       Date:  2015-06-17       Impact factor: 6.698

6.  Receptor editing and genetic variability in human autoreactive B cells.

Authors:  Julie Lang; Takayuki Ota; Margot Kelly; Pamela Strauch; Brian M Freed; Raul M Torres; David Nemazee; Roberta Pelanda
Journal:  J Exp Med       Date:  2015-12-22       Impact factor: 14.307

7.  Human Cytomegalovirus Induces Cellular and Humoral Virus-specific Immune Responses in Humanized BLT Mice.

Authors:  Lindsey B Crawford; Rebecca Tempel; Daniel N Streblow; Craig Kreklywich; Patricia Smith; Louis J Picker; Jay A Nelson; Patrizia Caposio
Journal:  Sci Rep       Date:  2017-04-20       Impact factor: 4.379

8.  Engineering Protein-Secreting Plasma Cells by Homology-Directed Repair in Primary Human B Cells.

Authors:  King L Hung; Iana Meitlis; Malika Hale; Chun-Yu Chen; Swati Singh; Shaun W Jackson; Carol H Miao; Iram F Khan; David J Rawlings; Richard G James
Journal:  Mol Ther       Date:  2017-11-22       Impact factor: 11.454

Review 9.  Potential Pitfalls of the Humanized Mice in Modeling Sepsis.

Authors:  Krzysztof Laudanski; Michael Stentz; Matthew DiMeglio; William Furey; Toby Steinberg; Arpit Patel
Journal:  Int J Inflam       Date:  2018-09-02

Review 10.  Humanized Mice as an Effective Evaluation System for Peptide Vaccines and Immune Checkpoint Inhibitors.

Authors:  Yoshie Kametani; Yusuke Ohno; Shino Ohshima; Banri Tsuda; Atsushi Yasuda; Toshiro Seki; Ryoji Ito; Yutaka Tokuda
Journal:  Int J Mol Sci       Date:  2019-12-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.